Titan Pharmaceuticals Inc Sustainability Reports

Titan Pharmaceuticals, Inc. operates as a subsidiary of Black Titan Corporation following its 2025 merger. It was historically engaged in developing therapeutics utilizing long-term drug delivery mechanisms for chronic diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300NOUZGB2ZNVJ794

FIGI: BBG001S72H65

9 reports from 2000 to 2024

• Titan Pharmaceuticals Inc 2024 Annual Report on Form 10-K
• Titan Pharmaceuticals Inc 2023 Form 10-K
• Titan Pharmaceuticals Inc 2022 Annual Report on Form 10-K
• Titan Pharmaceuticals Inc 2021 Annual Report on Form 10-K
• Titan Pharmaceuticals Inc 2020 Annual Report on Form 10-K